Ultra-small BaGdF5-based upconversion nanoparticles as drug carriers and multimodal imaging probes

Biomaterials

Volumn 35, Issue 6, 2014, Pages 2011-2023

  Yang, Dongmei ^a   Dai, Yunlu ^a   Liu, Jianhua ^b   Zhou, Ying ^c   Chen, Yinyin ^a   Li, Chunxia ^a   Ma, Ping'an ^a   Lin, Jun ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^c JILIN UNIVERSITY   (China)

Author keywords

BaGdF5; Drug delivery; Multimodal imaging; Upconversion nanoparticle

Indexed keywords

BAGDF5; CANCER THERAPY AND BIOIMAGING; DRUG RELEASE PROPERTIES; DRUG-DELIVERY SYSTEMS; MULTI-MODAL IMAGING; UP-CONVERSION LUMINESCENCE; UPCONVERSION NANOPARTICLES; X-RAY COMPUTED TOMOGRAPHY;

CYTOTOXICITY; DRUG DELIVERY; MAGNETIC RESONANCE; NANOPARTICLES;

COMPUTERIZED TOMOGRAPHY;

DOXORUBICIN; DRUG CARRIER; NANOPARTICLE; ULTRA SMALL BAGDF5 NANOPARTICLE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; UPCONVERSION NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER THERAPY; CELL VIABILITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; FIBER OPTICS; HELA CELL; IMAGING; IN VITRO STUDY; IN VIVO STUDY; LUMINESCENCE; MOLECULAR PROBE; MOUSE; MULTIMODAL IMAGING PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PH; PRIORITY JOURNAL; X RAY; BAGDF(5); CHEMISTRY; FLOW CYTOMETRY; HELA CELL LINE; HUMAN; METHODOLOGY; MULTIMODAL IMAGING;

MUS;

BAGDF(5); DRUG DELIVERY; MULTIMODAL IMAGING; UPCONVERSION NANOPARTICLE;

DOXORUBICIN; DRUG CARRIERS; FLOW CYTOMETRY; HELA CELLS; HUMANS; MULTIMODAL IMAGING; NANOPARTICLES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84890226974     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.018     Document Type: Article

References (63)

1. Yang P.P., Gai S.L., Lin J. Functionalized mesoporous silica materials for controlled drug delivery. Chem Soc Rev 2012, 41:3679-3698.
2. Cheng K., Sun S.H. Recent advances in syntheses and therapeutic applications of multifunctional porous hollow nanoparticles. Nano Today 2010, 5:183-196.
3. Kim M.H., Na H.K., Kim Y.K., Ryoo S.R., Cho H.S., Lee K.E., et al. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery. ACS Nano 2011, 5:3568-3576.
4. Qian H.S., Guo H.C., Ho P.C.L., Mahendran R., Zhang Y. Mesoporous-silica-coated up-conversion fluorescent nanoparticles for photodynamic therapy. Small 2009, 5:2285-2290.
5. Zhang F., Braun G.B., Pallaoro A., Zhang Y.C., Shi Y.F., Cui D.X., et al. Mesoporous multifunctional upconversion luminescent and magnetic "nanorattle" materials for targeted chemotherapy. Nano Lett 2012, 12:61-67.
6. 3+@hydrogel core-shell hybrid microspheres. ACS Nano 2012, 6:3327-3338.
7. Xing R.M., Liu S.H. Facile synthesis of the fluorescent porous zinc sulfide nanospheres and their application for potential drug delivery and live cell imaging. Nanoscale 2012, 4:3135-3140.
8. Cheng L., Yang K., Li Y.G., Chen J.H., Wang C., Shao M.W., et al. Facile preparation of multifunctional upconversion nanoprobes for multimodal imaging and dual-targeted photothermal therapy. Angew Chem 2011, 123:7523-7528.
9. 4:Yb/Er upconversion nanoparticles for invivo imaging and drug delivery. Adv Mater 2012, 24:1226-1231.
10. Cheng L., Wang C., Liu Z. Upconversion nanoparticles and their composite nanostructures for biomedical imaging and cancer therapy. Nanoscale 2013, 5:23-37.
11. Wang C., Cheng L., Liu Z. Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials 2011, 32:1110-1120.
12. Wang F., Liu X.G. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 2009, 38:976-989.
13. 3 nanoparticles as robust down- and upconverting biolabels. Chem Eur J 2006, 12:5878-5884.
14. Feng W., Han C.M., Li F.Y. Upconversion-nanophosphor-based functional nanocomposites. Adv Mater 2013, 25:5287-5303.
15. Xiong L.Q., Yang T.S., Yang Y., Xu C.J., Li F.Y. Long-term invivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010, 31:7078-7085.
16. 4 nanocrystals. Angew Chem Int Ed 2011, 50:6306-6310.
17. Li C.X., Lin J. Rare earth fluoride nano-/microcrystals: synthesis, surface modification and Application. JMater Chem 2010, 20:6831-6847.
18. Haase M., Schäfer H. Upconverting nanoparticles. Angew Chem Int Ed 2011, 50:5808-5829.
19. Xiong L.Q., Chen Z.G., Tian Q.W., Cao T.Y., Xu C.J., Li F.Y. High contrast upconversion luminescence targeted imaging invivo using peptide-labeled nanophosphors. Anal Chem 2009, 81:8687-8694.
20. 3+ nanoparticles withnear-infrared to near-infrared upconversion. JMater Chem 2011, 21:16589-16596.
21. Liu J.N., Bu W.B., Zhang S.J., Chen F., Xing H.Y., Pan L.M., et al. Controlled synthesis of uniform and monodisperse upconversion core/mesoporous silica shell nanocomposites for bimodal imaging. Chem Eur J 2012, 18:2335-2341.
22. 4:Yb,Tm nanocrystals. Biomaterials 2011, 32:9059-9067.
23. Chen D.Q., Yu Y.L., Huang F., Lin H., Huang P., Yang A.P., et al. Lanthanide dopant-induced formation of uniform sub-10 nm active-core/active-shell nanocrystals with near-infrared to near-infrared dual-modal luminescence. JMater Chem 2012, 22:2632-2640.
24. 4:Yb,Tm nanocrystals with efficient up-conversion fluorescence. Adv Funct Mater 2006, 16:2324-2329.
25. Xiong L.Q., Chen Z.G., Yu M.X., Li F.Y., Liu C., Huang C.H. Synthesis, characterization, and invivo targeted imaging of amine-functionalized rare-earth up-converting nanophosphors. Biomaterials 2009, 30:5592-5600.
26. 3+-doped nanoparticles for upconversion and magnetic resonance imaging: some critical notes onrecent progress and some aspects to be considered. Nanoscale 2012, 4:7309-7321.
27. 3 nanoparticles and their applications for optical and magnetic resonance imaging. JMater Chem 2012, 22:966-974.
28. Park Y., Kim H.M., Kim J.H., Moon K.C., Yoo B., Lee K.T., et al. Theranostic probe based on lanthanide-doped nanoparticles for simultaneous invivo dual-modal imaging and photodynamic therapy. Adv Mater 2012, 24:5755-5761.
29. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
30. Setua S., Menon D., Asok A., Nair S., Koyakutty M. Folate receptor targeted, rare-earth oxide nanocrystals for bi-modal fluorescence and magnetic imaging of cancer cells. Biomaterials 2010, 31:714-729.
31. 1 magnetic resonance imaging. Chem Commun 2012, 48:10322-10324.
32. 4 nanocrystals. Adv Funct Mater 2009, 19:853-859.
33. 1 magnetic resonance imaging contrast agent. Adv Mater 2009, 21:4467-4471.
34. Frullano L., Meade T.J. Multimodal MRI contrast agents. JBiol Inorg Chem 2007, 12:939-949.
35. 4 core/shell nanocrystals with near infrared to near-infrared upconversion photoluminescence and magnetic resonance properties. Nanoscale 2011, 3:2003-2008.
36. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
37. 4 nanocrystals as potential optical/magnetic multimodal bioprobes. JAm Chem Soc 2012, 134:1323-1330.
38. 1 MRI contrast enhancement. Chem Mater 2011, 23:3714-3722.
39. 3+ doped fluoride nanophosphors. Nano Lett 2008, 8:3834-3838.
40. Zhou J., Sun Y., Du X.X., Xiong L.Q., Hu H., Li F.Y. Dual-modality invivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
41. Liu Y.L., Ai K.L., Liu J.H., Yuan Q.H., He Y.Y., Lu L.H. Ahigh-performance ytterbium-based nanoparticulate contrast agent for invivo X-ray computed tomography imaging. Angew Chem Int Ed 2012, 51:1437-1442.
42. 4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-ray computed tomography and magnetic resonance. Biomaterials 2012, 33:5394-5405.
43. Xing H.Y., Bu W.B., Zhang S.J., Zheng X.P., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
44. 5:Yb/Er. Nanoscale 2012, 4:5118-5124.
45. Longmire M., Choyke P.L., Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 2008, 3:703-717.
46. 3+ nanoparticles with enhanced near-infrared to near-infrared upconversion photoluminescence. ACS Nano 2010, 4:3163-3168.
47. Bridot J.L., Faure A.C., Laurent S., Rivière C., Billotey C., Hiba B., et al. Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for invivo imaging. JAm Chem Soc 2007, 129:5076-5084.
48. Mai H.X., Zhang Y.W., Si R., Yan Z.G., Sun L.D., You L.P., et al. High-quality sodium rare-earth fluoride nanocrystals: controlled synthesis and optical properties. JAm Chem Soc 2006, 128:6426-6436.
49. 3+ nanoparticles by active-shell modification. JMater Chem 2011, 21:5923-5927.
50. Bae Y., Nishiyama N., Kataoka K. Invivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments. Bioconjug Chem 2007, 18:1131-1139.
51. Etrych T., Chytil P., Jelíínková M., Říhová B., Ulbrich K. Synthesis of HPMA copolymers containing doxorubicin bound via a hydrazone linkage effect of spacer on drug release and invitro cytotoxicity. Macromol Biosci 2002, 2:43-52.
52. 4:Yb,Er upconversion nanoparticles. ACS Nano 2009, 3:1580-1586.
53. 4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
54. 3+ nanoparticles for therapy and sensing of drug delivery by luminescence resonance energy transfer. Biomaterials 2012, 33:8704-8713.
55. Lee C.H., Cheng S.H., Huang I.P., Souris J.S., Yang C.S., Mou C.Y., et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics. Angew Chem 2010, 122:8390-8395.
56. 4 nanoparticle cores and a PEG-functionalized porous silica shell. Chem Commun 2010, 46:8633-8635.
57. Vetrone F., Naccache R., Mahalingam V., Morgan C.G., Capobianco J.A. The active-core/active-shell approach: a strategy to enhance the upconversion luminescence in lanthanide-doped nanoparticles. Adv Funct Mater 2009, 19:2924-2929.
58. 3+ nanocrystals. Chem Mater 2009, 21:1847-1851.
59. Lu J., Liong M., Li Z.X., Zink J.I., Tamanoi F. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 2010, 6:1794-1805.
60. Drummond D.C., Zignani M., Leroux J.C. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 2000, 39:409-460.
61. Bhujwalla Z.M., Artemov D., Ballesterors P., Cerdan S., Gillies R.J., Solaiyappan M. Combined vascular and extracellular pH imaging of solid tumors. NMR Biomed 2002, 15:114-119.
62. Jokerst J.V., Lobovkina T., Zare R.N., Gambhir S.S. Nanoparticle PEGylation for imaging and therapy. Nanomedicine 2011, 6:715-728.
63. Burtea C., Laurent S., Elst L.V., Muller R.N. Contrast agents: magnetic resonance. Handbook Exp Pharmacol 2008, 185:135-165.